171 related articles for article (PubMed ID: 32914644)
1. Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.
Moore RM; Sun Z; Juran BD; Lazaridis KN
Epigenomics; 2020 Aug; 12(16):1363-1375. PubMed ID: 32914644
[No Abstract] [Full Text] [Related]
2. Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases.
Ostrowski J; Goryca K; Lazowska I; Rogowska A; Paziewska A; Dabrowska M; Ambrozkiewicz F; Karczmarski J; Balabas A; Kluska A; Piatkowska M; Zeber-Lubecka N; Kulecka M; Habior A; Mikula M; ;
Sci Rep; 2019 May; 9(1):7190. PubMed ID: 31076612
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profile of liver tissue in end-stage cholestatic liver disease.
Cheung AC; Juran BD; Schlicht EM; McCauley BM; Atkinson EJ; Moore R; Heimbach JK; Watt KD; Wu TT; LaRusso NF; Gores GJ; Sun Z; Lazaridis KN
Epigenomics; 2022 Apr; 14(8):481-497. PubMed ID: 35473391
[TBL] [Abstract][Full Text] [Related]
4. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
6. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
7. Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
Stallhofer J; Denk GU; Glas J; Laubender RP; Göke B; Rust C; Brand S; Pusl T
Digestion; 2011; 84(1):29-35. PubMed ID: 21304239
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.
de Krijger M; Hageman IL; Li Yim AYF; Verhoeff J; Garcia Vallejo JJ; van Hamersveld PHP; Levin E; Hakvoort TBM; Wildenberg ME; Henneman P; Ponsioen CY; de Jonge WJ
Front Immunol; 2022; 13():840935. PubMed ID: 35371111
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.
Punia S; Juran BD; Ali AH; Schlicht EM; Moore RM; Sun Z; Lazaridis KN
BMC Gastroenterol; 2021 Apr; 21(1):149. PubMed ID: 33794792
[TBL] [Abstract][Full Text] [Related]
12. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
13. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
[TBL] [Abstract][Full Text] [Related]
15. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
16. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.
Pauli-Magnus C; Kerb R; Fattinger K; Lang T; Anwald B; Kullak-Ublick GA; Beuers U; Meier PJ
Hepatology; 2004 Mar; 39(3):779-91. PubMed ID: 14999697
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.
Bernuzzi F; Marabita F; Lleo A; Carbone M; Mirolo M; Marzioni M; Alpini G; Alvaro D; Boberg KM; Locati M; Torzilli G; Rimassa L; Piscaglia F; He XS; Bowlus CL; Yang GX; Gershwin ME; Invernizzi P
Clin Exp Immunol; 2016 Jul; 185(1):61-71. PubMed ID: 26864161
[TBL] [Abstract][Full Text] [Related]
18. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
19. Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output.
Dyson JK; Elsharkawy AM; Lamb CA; Al-Rifai A; Newton JL; Jones DE; Hudson M
Liver Int; 2015 May; 35(5):1633-41. PubMed ID: 25363895
[TBL] [Abstract][Full Text] [Related]
20. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
